Lastimado, Generose M.
HRN: 11-89-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/06/2022
12/12/2022
IVT
4.5g IVT Now ANST Then 2.25g IVT Q8
4.5g IVT Now ANST Then 2.25g IVT Q8
Cystic Fibrosis; CAP MR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose